EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu + /Cu 2+ ‐Targeting Ligand in the Context of Alzheimer's Disease

Barbara Marinho Barbosa iD, Charlène Esmieu iD, Antal Galvácsi iD, Mariana Viana Costa iD, Adèle Brison, Sonia M Ladeira iD, Jade de Oliveira iD, Csilla Kállay iD, Christelle Hureau iD, Nicolás A Rey iD

Chemistry – A European Journal · 2026

DOI: 10.1002/chem.202502754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Barbara Marinho Barbosa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Thiosemicarbazones, Copper, Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANR project Copperation, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The binding of copper ions to amyloid‐β (Aβ) peptide leads to reactive oxygen species (ROS) formation and toxic soluble oligomers, contributing to oxidative stress in Alzheimer's disease (AD). Thus, studying compounds with moderate copper affinity is a promising strategy to prevent its interaction with Aβ and reduce toxicity. Here, we evaluated a new tri‐coordinating thiosemicarbazone ( HXE ) with chelating properties to regulate cuprotoxicity in AD. The ligand was nontoxic against HT‐22 hippocampal neuronal cells and bound Cu + and Cu 2+ at pH 7.4, with affinity constants (log K cond ) of 8.7 and 12.3, respectively, showing high selectivity over Zn 2+ (log K app = 5.0). In the presence of Aβ and Cu 2+ , HXE formed stable ternary complexes at physiological pH. Ascorbate consumption and coumarin‐3‐carboxylic acid fluorescence assays showed that the ligand significantly reduces Cu(Aβ 16 )‐mediated ROS production. It also prevented Cu 2+ ‐induced modulation of Aβ 40 self‐assembly and restored the typical fibrillar structure of apo‐Aβ 40 aggregates. Overall, HXE effectively modulates metal‐associated Aβ toxicity and emerges as a promising candidate for AD bioinorganic management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesCopperAlzheimer DiseaseAmyloid beta-PeptidesImidazolesChelating AgentsLigandsReactive Oxygen SpeciesHumansOxidative StressCoordination ComplexesAnimalsMice

Stichwörter der Autor:innen

Alzheimer's diseaseAÎ2 aggregationCopperROSThiosemicarbazone

Substanzen

ThiosemicarbazonesCopperAmyloid beta-PeptidesLigandsReactive Oxygen SpeciesImidazolesCoordination ComplexesChelating Agents

Autor:innen und Institutionen

  • Department of Chemistry, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil.
  • Laboratoire De Chimie de Coordination (LCC), CNRS, University of Toulouse, Toulouse, France.
  • Department of Inorganic and Analytical Chemistry, University of Debrecen, Debrecen, Hungary.
  • Department of Biochemistry, Basic Health Sciences Institute, Federal University of Rio Grande Do Sul, Rio Grande do Sul, Brazil.

ORCID-Profile: Barbara Marinho Barbosa, Charlène Esmieu, Antal Galvácsi, Mariana Viana Costa, Sonia M Ladeira, Jade de Oliveira, Csilla Kállay, Christelle Hureau, Nicolás A Rey

Förderung

  • ANR project Copperation
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Marinho Barbosa, B., Esmieu, C., Galvácsi, A., Costa, M. V., Brison, A., Ladeira, S. M., de Oliveira, J., Kállay, C., Hureau, C., & Rey, N. A. (2026). Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu + /Cu 2+ ‐Targeting Ligand in the Context of Alzheimer's Disease. Chemistry – A European Journal. https://doi.org/10.1002/chem.202502754

Vancouver

Marinho Barbosa B, Esmieu C, Galvácsi A, Costa MV, Brison A, Ladeira SM, et al. Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu + /Cu 2+ ‐Targeting Ligand in the Context of Alzheimer's Disease. Chemistry – A European Journal. 2026. doi:10.1002/chem.202502754

BibTeX
@article{MarinhoBarbosa2026,
  author = {Marinho Barbosa, Barbara and Esmieu, Charlène and Galvácsi, Antal and Costa, Mariana Viana and Brison, Adèle and Ladeira, Sonia M and de Oliveira, Jade and Kállay, Csilla and Hureau, Christelle and Rey, Nicolás A},
  title = {Evaluation of a New Methylimidazole‐Containing Thiosemicarbazone as a Cu + /Cu 2+ ‐Targeting Ligand in the Context of Alzheimer's Disease},
  journal = {Chemistry – A European Journal},
  year = {2026},
  doi = {10.1002/chem.202502754}
}
Kostenlos starten →